Nature of the main contaminant in the anti malaria drug primaquine diphosphate: A qualitative isomer analysis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 800, Issue 1-2, 2004, Pages 211-223

  Brondz, Ilia ^a   Mantzilas, Dimitris ^a   Klein, Uwe ^a   Ekeberg, Dag ^b   Hvattum, Erlend ^b   Lebedeva, Marina N ^c   Mikhailitsyn, Felix S ^c   Souleimanov, Gasan D ^c   Røe, Johan ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c Martsinovsky Inst Med P   (Russian Federation)

^d Weifa AS   (Norway)

Author keywords

Primaquine; Quinocide

Indexed keywords

ELECTRON TRANSPORT PROPERTIES; IMPURITIES; ISOMERS; LIQUID CHROMATOGRAPHY; MALARIA CONTROL; MASS SPECTROMETRY; TOXICITY;

MASS FRAGMENTATION; PHARMACEUTICAL INDUSTRY;

DRUG PRODUCTS;

ANTIMALARIAL AGENT; PRIMAQUINE; QUINOCIDE; UNCLASSIFIED DRUG;

BATCH FERMENTATION; CHIRALITY; CHLAMYDOMONAS REINHARDTII; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE; DRUG CONTAMINATION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG INDUSTRY; ELECTRON TRANSPORT; EUKARYOTE; EXPERIMENTAL MODEL; GREEN ALGA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; ISOMER; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TOXICITY TESTING;

ALGAE; CHLAMYDOMONAS; CHLAMYDOMONAS REINHARDTII; CHLOROPHYTA; EUKARYOTA;

EID: 0347416823     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.09.042     Document Type: Conference Paper

References (38)

1. E. Mutschler, H. Derendorf, M. Scha'fer-Korting, K. Elrod, K.S. Estes (Eds.), Drug Actions Basic Principles and Therapeutic Aspects, Scientific Publishers, Stuttgart, 1995, p. 564.
2. Extra Pharmacopoeia, Martindale, 25th ed., in: R.G. Todd (Ed.), The Pharmaceutical Press, London, 1967, p. 315.
3. Elderfield R.C., Gensler W.J., Head J.D., Hageman H.A., Kremer C.B., Wright J.B., Holley A.D., Williamson B., Galbreath J., Wielderhold L. III, Flohardt R., Kupchan S.M., Williamson T.A., Biratein O. J. Am. Chem. Soc. 68:1946;1524.
4. Elderfield R.C., Mertel H.E., Mitch R.T., Wempen I.M., Werble E. J. Am. Chem. Soc. 77:1955;4816.
5. Braude M.V., Stavrovskaja V.I. J. Gen. Chem., USSR. 26:1956;999.
6. Braude M.V., Stavrovskaja V.I. Med. Prom. 11:1957;19.
7. British Pharmacopoeia, vol. I, HMSO, London, 1988, p. 462.
8. British Pharmacopoeia, 1988, HMSO, London, 1990, p. 1252 (Addendum).
9. British Pharmacopoeia, vol. I, HMSO, London, 1993, p. 541.
10. British Pharmacopoeia, 1993, HMSO, London, 1997, p. 2015 (Addendum).
11. European Pharmacopoeia, Third ed., Council of Europe, Strasbourg, 1997, p. 1385.
12. British Pharmacopoeia, vol. I, HMSO, London, 2000, p. 1285.
13. European Pharmacopoeia, Third ed., Suppl., Council of Europe, Strasbourg, 2001, p. 1323.
14. Sin D.D., Shafran S.D. J. Acquired Immune Deficiency Syndromes Hum. Retrovirol. 12(5):1996;477.
15. Coleman M.D., Coleman N.A. Drug Safety. 14(6):1996;394.
16. Marrs T.C., Bright J.E., Morris B.C. Toxicol. Lett. 36(3):1987;281.
17. Kantor G.S. New Engl. J. Med. 327(20):1992;1461.
18. Allahyari R., Srtother A., Tilton B.E., Fraser I.M. Abs. Papers Am. Chem. Soc. 192:1986;86.
19. Schmidt I.G., Schmidt L.H. J. Neuropath. Exp. Neur. 7:1948;369.
20. Schmidt I.G., Schmidt L.H. J. Neuropath. Exp. Neur. 8:1948;337.
21. D. Bullimore, Eur. J. Gastroenterol. Hepatol. 5 (1993) 63.
22. A.M. Rønn, J. Rønne-Rasmussen, P.C. Gøtzsche, I.C. Bygbjerg, Trop. Med. Int. Health 3 (2) (1998) 83.
23. Elmofty M.M., Khudoley V.V., Sakr S.A., Abdelgawad H.S. Nutr. Cancer Int. J. 18(2):1992;191.
24. Y. Machida, H. Nishi, K. Nakamura, H. Nakai, T. Sato, J. Chromatogr. A 805 (1998) 85.
25. Baker J.K., McChesney J.D. J. Pharm. Sci. 77(5):1988;380.
26. Baker J.K., Yarber R.H., Nanayakkara N.P.D., McChesney J.D., Homo F., Landau I. Pharm. Res. 7(1):1990;91.
27. E.H. Harris (Ed.), The Chlamydomonas Source Book, Academic Press, San Diego, 1989, p. 1.
28. M.L. Hitchman, in: Measurement of Dissolved Oxygen, Wiley, New York, 1978, p. 255.
29. N. Sueoka, Proc. Natl. Acad. Sci. U.S.A. 46 (1960) 83.
30. D.I. Arnon, Plant Physiol. 24 (1949) 1.
31. L.S. Goodman, A. Gilman (Eds.), The Pharmacological Basis of Therapeutics, Fourth ed., Collier MacMillan, London, 1970, p. 1112.
32. D. McChesney, J.K. Baker, A.M. Clark, C.D. Hufford, in: W.H. Wernsdorfer, P.I. Trigg (Eds.), Primaquine Pharmacokinetics, Metabolism, Toxicity and Activity, Wiley, Chichester, 1984, p. 3.
33. L.H. Schmidt, S. Alexander, L. Allen, J. Rasco, Antimicrob. Agents Chemother. 12 (1) (1977) 51.
34. A. Breckenridge, in: W.H. Wernsdorfer, P.I. Trigg (Eds.), Primaquine Pharmacokinetics, Metabolism, Toxicity and Activity, Wiley, Chichester, 1984, p. 155.
35. Grinberg L.N., Shalev O., Goldfarb A., Rachmilewitz E.A. Biochem. Biophys. Acta. 1139(3):1992;248.
36. Nishi H., Izumoto S., Nakamura K., Nakai H., Sato T. Chromatographia. 42(11-12):1996;617.
37. Peytavin G., Gimenez F., Genissel B., Gillotin C., Baillet A., Wainer I.W., Farinoti R. Chirality. 5:1993;173.
38. Mesnil H., Schanne-Klein M.C., Hache F., Alexandere M., Lemercier G., Andraud C. Chem. Phys. Lett. 338:2001;269.